Wells Fargo Marvell · MRVL

Wells Fargo Boosts Marvell Price Target to $310

1 min read Reproduced verbatim
Rating
Overweight
Unchanged
Target
$310
from $240 (+29%)
Upside
+84%
MRVL at $168 today
Wells Fargo and Marvell logos

What the analyst said

Wells Fargo analyst Aaron Rakers raised the price target on Marvell (NASDAQ: MRVL) to $310 (from $240) while maintaining an Overweight rating on August 24, 2026.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

MRVL trades at $168. The 24 analysts who set a target in the last 3 months range from $175 to $433, with a median of $300. This $310 target is 3% above the median.

Since the note MRVL has moved −29% (from $237). 12-month window: day 71 of 365, closes on August 24, 2027.

Track record

This callOpen: MRVL has not reached $310 yet. This 12-month target is scored on August 24, 2027.

Firm track recordWells Fargo: 65% of its 34 targets at least a year old were reached within 12 months (#22 of 26 firms). Accuracy ranking →

Wells Fargo on Marvell

Wells Fargo price targets on Marvell

5 calls from May 20, 2026 to November 3, 2026. The target went from $195 to $285 (+46%). The rating stayed Buy.

Wells Fargo targetMRVL share price
  1. November 3, 2026Target cut from $365 (−22%)Buy$285
  2. October 7, 2026Target raised from $310 (+18%)Buy$365
  3. August 24, 2026 This noteTarget raised from $240 (+29%)Buy$310
  4. May 28, 2026Target raised from $195 (+23%)Buy$240
  5. May 20, 2026Earliest call shownBuy$195
Share

Other analysts on Marvell

StoneXBuy Kept rating and price target Nov 3 $375maintained UBSBuy Kept rating and price target Nov 3 $350maintained RBC CapitalBuy Cut price target −41%, kept rating Nov 3 $250from $425 NeedhamBuy Cut price target −25%, kept rating Nov 3 $300from $400 Bank of AmericaHold Downgraded, cut price target −44% Nov 3 $225from $400
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.